Literature DB >> 16573590

Hepatitis C infection and alcohol use: A dangerous mix for the liver and antiviral immunity.

Gyongyi Szabo1, Costica Aloman, Stephen J Polyak, Steven A Weinman, Jack Wands, Sam Zakhari.   

Abstract

This article presents the proceedings of a symposium presented at the meeting of the Research Society on Alcoholism, held in Santa Barbara, California, in June 2005. The organizers and chairs were Sam Zakhari and Gyongyi Szabo. The presentations included (1) Mitochondrial Abnormalities Induced by Hepatitis C -Alcohol Interaction by Steven Weinman; (2) Effects of Acute and Chronic Ethanol on Innate Antiviral Signaling Pathways, Hepatitis C Replication, and Human Liver Cell Transcription by Stephen Polyak; (3) Ethanol Alters Dendritic Cell Function In Vivo and Impairs the Subsequent Cellular Immune Responses to Hepatitis C Proteins by Costica Aloman; and (4) Pathogenic Interactions Between Hepatitis C Virus and Alcohol Use in Humans: Dendritic Cells as Common Targets by Gyongyi Szabo. This symposium summarizes the state of knowledge of cellular and molecular pathways by which alcohol and HCV have pathogenic interactions resulting in depression of the immune response and liver damage in chronic HCV infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16573590     DOI: 10.1111/j.1530-0277.2006.00083.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  32 in total

1.  Inflammatory cytokines and mortality in a cohort of HIV-infected adults with alcohol problems.

Authors:  Daniel Fuster; Debbie M Cheng; Emily K Quinn; Kaku A Armah; Richard Saitz; Matthew S Freiberg; Jeffrey H Samet; Judith I Tsui
Journal:  AIDS       Date:  2014-04-24       Impact factor: 4.177

Review 2.  Impact of etiological treatment on prognosis.

Authors:  Chien-Wei Su; Ying-Ying Yang; Han-Chieh Lin
Journal:  Hepatol Int       Date:  2017-07-12       Impact factor: 6.047

Review 3.  MicroRNAs in alcoholic liver disease.

Authors:  Gyongyi Szabo; Abhishek Satishchandran
Journal:  Semin Liver Dis       Date:  2015-01-29       Impact factor: 6.115

4.  Versican: a novel modulator of hepatic fibrosis.

Authors:  Terence N Bukong; Sean B Maurice; Barinder Chahal; David F Schaeffer; Paul J Winwood
Journal:  Lab Invest       Date:  2016-01-11       Impact factor: 5.662

Review 5.  Alcoholic hepatitis and HCV interactions in the modulation of liver disease.

Authors:  C S Punzalan; T N Bukong; G Szabo
Journal:  J Viral Hepat       Date:  2015-03-06       Impact factor: 3.728

Review 6.  Hepatitis C virus and ethanol alter antigen presentation in liver cells.

Authors:  Natalia A Osna
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

Review 7.  A recent perspective on alcohol, immunity, and host defense.

Authors:  Gyongyi Szabo; Pranoti Mandrekar
Journal:  Alcohol Clin Exp Res       Date:  2008-12-02       Impact factor: 3.455

Review 8.  Hepatitis C virus and alcohol.

Authors:  Larry Siu; Julie Foont; Jack R Wands
Journal:  Semin Liver Dis       Date:  2009-04-22       Impact factor: 6.115

9.  Human ezrin-moesin-radixin proteins modulate hepatitis C virus infection.

Authors:  Terence N Bukong; Karen Kodys; Gyongyi Szabo
Journal:  Hepatology       Date:  2013-09-17       Impact factor: 17.425

10.  Interleukin-6 is associated with noninvasive markers of liver fibrosis in HIV-infected patients with alcohol problems.

Authors:  Daniel Fuster; Judith I Tsui; Debbie M Cheng; Emily K Quinn; Kaku A Armah; David Nunes; Matthew S Freiberg; Jeffrey H Samet
Journal:  AIDS Res Hum Retroviruses       Date:  2013-05-17       Impact factor: 2.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.